mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex
By John T. Cunningham, J. T. Rodgers, Daniel H Arlow, F. Vazquez, Vamsi K. Mootha, P. Puigserver. Nature, 2007
1,397 citations recorded by the source corpus.
Subfields: Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/a1a4a9cf6d88e2a29d37dab11564d51d1dd57acf
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- David M. Sabatini
- M. Laplante
- B. Manning
- R. A. Saxton
- Craig B. Thompson
- R. Shaw
- Timothy R. Peterson
- Michael Pollak
In Physiology
- David M. Sabatini
- R. A. Saxton
- M. Laplante
- Nahum Sonenberg
- B. Manning
- J. St-Pierre
- M. Hock
- Eyal Gottlieb
Citations in the corpus
- Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways (2011, background): “As mitochondria are the major site of β-oxidation and mTORC1 signaling has been proposed to promote mitochondrial biogenesis (Cunningham et al., 2007), we also measured levels of mitochondrial markers.”
- Transcriptional control of mitochondrial biogenesis and function. (2009, background): “These protein surfaces include leucine-rich motifs that mediate interactions with nuclear receptors (16, 45, 94, 95); a conserved DHDY motif that binds HCF and presumably enables interactions with GABP (17, 33, 34); and less well-characterized interfaces for NRF-1, YY1, and other transcription facto”
- Reprogramming of fatty acid metabolism in cancer (2019, background): “Furthermore, mTORC1 and mTORC2 downstream of oncogenic PI3K promote oxidative phosphorylation through PGC-1α-dependent mitochondrial biosynthesis, and synthesis of cardiolipins, which enhance respiration and improve mitochondrial activity.(91,102) Therefore, hyperactive PI3K signalling provides a cl”
- PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism (2020, background): “Interestingly, PGC-1α is able to self-regulate its own transcription through YingYang1 (YY1), in a direct interaction that requires the presence of mTOR, thus stimulating mitochondrial activity [28].”
- Mitochondrial DNA: more than an evolutionary bystander (2014, background): “2006), and mTOR inhibition reduced the association of PGC-1a with the transcription factor YY1, leading to lower expression of several genes encoding mitochondrial proteins (Cunningham et al. 2007).”
- mTOR signaling in growth control and disease (2012, background): “Additional evidence is needed to support this connection because the YY1 response element was not identified as a motif enriched in the promoters of mTORC1-regulated genes (Düvel et al., 2010) and little endogenous mTORC1 is found in the nucleus (Sancak et al., 2010; Sancak et al., 2008; Zoncu et a”
- mTOR Signaling in Growth, Metabolism, and Disease (2017, background): “Paradoxically, however, chronic pharmacological inhibition of mTORC1 using rapamycin has the opposite effect, causing insulin resistance and impaired glucose homeostasis (Figure 4D; Cunningham et al., 2007).”
- Regulation of Immune Responses by mTOR (2011, background): “Indeed, mTORC1 inhibition leads to an increase in autophagy, whereas mitochondrial biosynthesis is enhanced in the setting of increased mTORC1 activation (39, 40).”
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012, background): “…1970; Tallal et al., 1970). mTORC1 has also been shown to have direct effects on promoting mitochondrial biogenesis, in part via a transcriptional complex that promotes the function of PGC-1a (Bentzinger et al., 2008; Cunningham et al., 2007; Ramanathan and Schreiber, 2009; Schieke et al., 2006).”